tirzepatide urinary tract infection 🚨 New Research Alert! 🚨 From @sexmedresearch For the first time, a GLP-1/GIP medication (tirzepatide) has been shown to successfully treat Persistent Genital Arousal Disorder (PGAD/GPD) — a rare, painful, and often semaglutide bladder issues and UTI:

This type of treatment is ideal if your main concern is sun tan rather than acne, dryness, or ageing

After six months, the goal shifts from repair to optimization. Long-term users generally report a higher baseline of health

While early-stage EC can be effectively treated through surgical intervention or a combination of radiotherapy, a subset of patients seeks non-surgical treatment options, particularly those desiring to preserve fertility

[53] showed that cells in periosteal explants stimulated with IGF-1 (100 ng/mL) for two days differentiated into chondrocytes

Randomised clinical trials have demonstrated very low rates of hypoglycaemia with GLP-1 RAs when used as a monotherapy or in a combination therapy with other glucose-lowering drugs [16, 18, 20, 22, 24, 26, 28]

0.95) (Extended Data Fig